Published at the
Stock prices for mpox vaccine maker Bavarian Nordic surged after the World Health Organization (WHO) on Thursday declared mpox a global public health emergency.
The company’s share prices jumped 17% in early trading in Copenhagen today, Forbes reported, after climbing 12% yesterday when the WHO made its announcement. In the U.S., shares were up 33% this morning.
The WHO cited recent outbreaks in the Democratic Republic of Congo (DRC) and neighboring nations in its declaration.
In the first known infection of its kind outside Africa, Sweden today confirmed a case of the highly contagious strain of mpox, according to NBC News. The WHO’s European regional office in Copenhagen said it was discussing with Sweden how best to manage the newly detected case, according to Medical Xpress.
This is the second time in two years the WHO has declared mpox a “public health emergency of international concern” PHEIC — pronounced “fake” — which is its highest form of an alert.
The announcement follows a declaration Tuesday by the Africa Centres for Disease Control and Prevention that mpox is a continent-wide public health emergency.
Notes from APS Radio News
Since the “covid” policies were implemented in March 2020, about 500 new billionaires were created.
During the first few years of its sales of the mRNA vaccine, Pfizer’s revenues increased by about $70 billion.
By November of 2020, in excess of 160,000 small and medium-sized businesses were shuttered by policies that included lockdowns.
In large measure, vaccine makers have legal immunity through the Prep Act and NCVIA.